🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Background: Breast cancer is the second most common cause of United States...
Status
Terminated
Location
National Institutes of Health Clinical Center
Start Date
2021-05-04
Trial ID
NCT04296942
Treatments Being Tested
TGF-β is a cytokine that is found to be upregulated in the bone marrow of p...
Status
Terminated
Location
Icahn School of Medicine at Mount Sinai
Start Date
2011-02
Trial ID
NCT01291784
Treatments Being Tested
The goal of this clinical trial is to: 1) evaluate the safety and recommend...
Status
Recruiting
Location
University of Nebraska Medical Center
Start Date
2025-05-12
Trial ID
NCT06579196
Treatments Being Tested
The purpose of this study is to determine if LY2382770 is safe and effectiv...
Status
Terminated
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2010-07
Trial ID
NCT01113801
Background: Some people with prostate cancer have a rise in prostate-speci...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2018-03-20
Trial ID
NCT03315871
Background: * GC1008 is a genetically engineered antibody designed to bloc...
Status
Completed
Location
Cancer Institute of New Jersey
Start Date
2006-07-09
Trial ID
NCT00923169
Treatments Being Tested
The purpose of this study is to determine the safety, tolerability, pharmac...
Status
Completed
Location
National Cancer Institute (NCI)
Start Date
2006-09
Trial ID
NCT00356460
Treatments Being Tested
The purpose of this study is to test safety of combining fresolimumab and l...
Status
Completed
Location
David Geffen School of Medicine at UCLA
Start Date
2011-07
Trial ID
NCT01401062
Treatments Being Tested
To find the highest dose of NK cells that can be given by vein and intraper...
Status
Recruiting
Location
MD Anderson Cancer Center
Start Date
2026-04-20
Trial ID
NCT07411599
Treatments Being Tested
The main purpose of this study is to evaluate the safety, tolerability, and...
Status
Completed
Location
University of Alabama at Birmingham Medical Center
Start Date
2015-01-01
Trial ID
NCT02423343
Treatments Being Tested